Moreover, luminal and HER2+ breast cancers showed hypermethylation, and normal samples and triple-negative breast cancer samples were neither hyper- nor hypo-methylated (Figure 14). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.